These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25471111)

  • 1. Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment.
    Chertoff J; Alam S; Black M; Elgendy IY
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25471111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis.
    Jack KL; Koopman WJ; Hulley D; Nicolle MW
    J Clin Neuromuscul Dis; 2016 Sep; 18(1):12-20. PubMed ID: 27552384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cholestasis due to azathioprine in Behcet's disease.
    Gisi K; Ispiroglu M; Kantarceken B; Sayar H
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
    Siramolpiwat S; Sakonlaya D
    Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine induced liver injury: a case report.
    Choudhary NS; Gupta S; Chawla YK; Duseja A; Dhiman RK; Das A
    Dig Dis Sci; 2012 Jun; 57(6):1717-8. PubMed ID: 22526581
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe azathioprine-induced liver injury 22 months after initiation of treatment.
    Cataletti G; Santagata F; Pastorelli L; Battezzati PM
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36543371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.
    Dhaliwal HK; Anderson R; Thornhill EL; Schneider S; McFarlane E; Gleeson D; Lennard L
    Hepatology; 2012 Oct; 56(4):1401-8. PubMed ID: 22488741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis.
    Bromberg MB; Wald JJ; Forshew DA; Feldman EL; Albers JW
    J Neurol Sci; 1997 Sep; 150(1):59-62. PubMed ID: 9260858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cholestatic hepatitis caused by azathioprine.
    Eisenbach C; Goeggelmann C; Flechtenmacher C; Stremmel W; Encke J
    Immunopharmacol Immunotoxicol; 2005; 27(1):77-83. PubMed ID: 15803861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    Ruiz-Clavijo D; Arín A; Vila JJ; Albéniz E; Picazo R; Casi M
    An Sist Sanit Navar; 2013 Sep; 36(2):353-6. PubMed ID: 24008542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.
    Narayanaswami P; Sanders DB; Thomas L; Thibault D; Blevins J; Desai R; Krueger A; Bibeau K; Liu B; Guptill JT;
    Lancet Neurol; 2024 Mar; 23(3):267-276. PubMed ID: 38365379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis.
    Hohlfeld R; Michels M; Heininger K; Besinger U; Toyka KV
    Neurology; 1988 Feb; 38(2):258-61. PubMed ID: 3340289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].
    Braun SA; Helbig D; Frank J; Hanneken S
    Hautarzt; 2012 Oct; 63(10):756-9. PubMed ID: 23008007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of azathioprine on chronic viral hepatitis in renal transplantation: a long-term, single-center, prospective study on azathioprine withdrawal.
    David-Neto E; Americo da Fonseca J; Jota de Paula F; Nahas WC; Sabbaga E; Ianhez LE
    Transplantation; 1999 Oct; 68(7):976-80. PubMed ID: 10532537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine in the treatment of myasthenia gravis.
    Witte AS; Cornblath DR; Parry GJ; Lisak RP; Schatz NJ
    Ann Neurol; 1984 Jun; 15(6):602-5. PubMed ID: 6742794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal hypertension secondary to azathioprine in myasthenia gravis.
    Fonseca V; Havard CW
    Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.
    Andrade RJ; Lucena MI; Fernández MC; Vega JL; García-Cortés M; Casado M; Guerrero-Sanchez E; Pulido-Fernandez F
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):887-90. PubMed ID: 12172412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenic crisis caused by azathioprine-induced fever].
    Tumani H; George A; Nau R
    Nervenarzt; 1997 Apr; 68(4):336-8. PubMed ID: 9273463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans.
    DePinho RA; Goldberg CS; Lefkowitch JH
    Gastroenterology; 1984 Jan; 86(1):162-5. PubMed ID: 6689657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.